Jacqz-Aigrain E, Guillonneau M
Unité de pharmacologie clinique, hôpital Robert-Debré, Paris, France.
Arch Pediatr. 1997 Jan;4(1):52-60. doi: 10.1016/s0929-693x(97)84310-2.
Steroid therapy, in combination with antibiotics for bacterial meningitis in paediatric patients remains controversial. Steroids, and primarily dexamethasone a very potent anti-inflammatory agent, regulate the liberation of various cytokines and inflammatory mediators such as prostaglandins, released during bacterial meningitis and leading to long term complications. Several clinical trials studying infants and children with bacterial meningitis due to Haemophilus influenzae have evaluated the beneficial effects of the administration of dexamethasone at the onset of antibiotherapy and demonstrated that dexamethasone reduced the risk of acquired sensorineural deafness (bilateral moderate or more severe hearing loss) and the incidence of neurological sequelae. Limited information is available for the other bacterial meningitis, although meningococcal meningitis will become more frequent with the use of effective anti-Haemophilus vaccines. In addition some Streptococcus pneumoniae are now resistant to third generation cephalosporins and the use of dexamethasone in that case may be at risk. Finally, no evidence is available for an effective role for dexamethasone in neonatal bacterial meningitis, although it is quite often administered in that age group.
在儿科患者中,类固醇疗法与抗生素联合用于治疗细菌性脑膜炎仍存在争议。类固醇,主要是地塞米松这种非常有效的抗炎药,可调节细菌性脑膜炎期间释放的各种细胞因子和炎症介质(如前列腺素)的释放,而这些物质会导致长期并发症。多项针对因流感嗜血杆菌引起细菌性脑膜炎的婴幼儿的临床试验,评估了在抗生素治疗开始时给予地塞米松的有益效果,并证明地塞米松降低了获得性感音神经性耳聋(双侧中度或更严重听力损失)的风险以及神经后遗症的发生率。对于其他细菌性脑膜炎,可用信息有限,尽管随着有效抗流感嗜血杆菌疫苗的使用,脑膜炎球菌性脑膜炎将变得更加常见。此外,一些肺炎链球菌现在对第三代头孢菌素耐药,在这种情况下使用地塞米松可能存在风险。最后,尽管地塞米松在新生儿细菌性脑膜炎中经常使用,但尚无证据表明其在该年龄组中有有效作用。